Enterocyte fatty acid-binding proteins (FABPs): Different functions of liver and intestinal FABPs in the intestine

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 93, Issue , 2015, Pages 9-16

  Gajda, Angela M ^a   Storch, Judith ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Fatty acid; Fatty acid binding protein; IFABP; Intestine; LFABP; Lipid

Indexed keywords

CANNABINOID 1 RECEPTOR; DIACYLGLYCEROL; ENDOCANNABINOID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; FATTY ACID BINDING PROTEIN 2; FATTY ACID BINDING PROTEIN 6; FATTY ACID TRANSPORTER; LONG CHAIN FATTY ACID; MESSENGER RNA; MONOACYLGLYCEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BODY WEIGHT; ENERGY BALANCE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENETIC POLYMORPHISM; HUMAN; INTESTINE; LIGAND BINDING; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; MALABSORPTION; NONHUMAN; STOICHIOMETRY; ANIMAL; INTESTINE CELL; LIVER; METABOLISM; MOUSE; TRANSGENIC MOUSE;

MAMMALIA; MUS;

ANIMALS; ENTEROCYTES; FATTY ACID-BINDING PROTEINS; HUMANS; INTESTINES; LIVER; MICE; MICE, TRANSGENIC;

EID: 84922782211     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.10.001     Document Type: Article

References (99)

1. Ockner R.K., Manning J.A. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J. Clin. Invest. 1974, 54:326-338.
2. Mishkin S., Stein L., Gatmaitan Z., Arias I.M. The binding of fatty acids to cytoplasmic proteins: binding to Z protein in liver and other tissues of the rat. Biochem. Biophys. Res. Commun. 1972, 47:997-1003.
3. Storch J., Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu. Rev. Nutr. 2008, 28:73-95.
4. Haunerland N.H., Spener F. Fatty acid-binding proteins--insights from genetic manipulations. Prog. Lipid Res. 2004, 43:328-349.
5. Hertzel A.V., Bernlohr D.A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol. Metab. 2000, 11:175-180.
6. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta 1998, 1391:287-306.
7. Córsico B., Liou H.L., Storch J. The alpha-helical domain of liver fatty acid binding protein is responsible for the diffusion-mediated transfer of fatty acids to phospholipid membranes. Biochemistry 2004, 43:3600-3607.
8. Corsico B., Cistola D.P., Frieden C., Storch J. The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes. Proc. Natl. Acad. Sci. U. S. A 1998, 95:12174-12178.
9. Chmurzyńska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J. Appl. Genet 2006, 47:39-48.
10. Storch J., Thumser A.E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 2010, 285:32679-32683.
11. Kaczocha M., Glaser S.T., Deutsch D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. U. S. A 2009, 106:6375-6380.
12. Piomelli D. More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology 2013, 1-7.
13. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
14. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., et al. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 1999, 274:2794-2801.
15. Jung K.-M., Clapper J.R., Fu J., Agostino G.D, Guijarro A., Thongkham D., et al. 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab. 2012, 15:299-310.
16. Lagakos W.S., Guan X., Ho S.-Y., Sawicki L.R., Corsico B., Kodukula S., et al. Liver Fatty Acid-binding Protein Binds Monoacylglycerol in Vitro and in Mouse Liver Cytosol. J. Biol. Chem. 2013, 288:19805-19815.
17. Caspary W.F. Physiology and pathophysiology of intestinal absorption. Am. J. Clin. Nutr. 1992, 55:299S-308S.
18. Guilmeau S., Niot I., Laigneau J.P., Devaud H., Petit V., Brousse N., et al. Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem. Cell Biol. 2007, 128:115-123.
19. Levy E., Ménard D., Delvin E., Montoudis A., Beaulieu J.-F., Mailhot G., et al. Localization, function and regulation of the two intestinal fatty acid-binding protein types. Histochem. Cell Biol. 2009, 132:351-367.
20. Pelsers M.M.A.L., Namiot Z., Kisielewski W., Namiot A., Januszkiewicz M., Hermens W.T., et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin. Biochem. 2003, 36:529-535.
21. Bass N.M., Manning J.A., Ockner R.K., Gordon J.I., Seetharam S., Alpers D.H. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. J. Biol. Chem. 1985, 260:1432-1436.
22. Zimmerman A.W., van Moerkerk H.T., Veerkamp J.H. Ligand specificity and conformational stability of human fatty acid-binding proteins. Int. J. Biochem. Cell Biol. 2001, 33:865-876.
23. Fujita M., Fujii H., Kanda T., Sato E., Hatakeyama K., Ono T. Molecular cloning, expression, and characterization of a human intestinal 15-kDa protein. Eur. J. Biochem. 1995, 233:406-413.
24. Miller K.R., Cistola D.P. Titration calorimetry as a binding assay for lipid-binding proteins. Mol. Cell. Biochem. 1993, 123:29-37.
25. Ono T. Studies of the FABP family: a retrospective. Mol. Cell. Biochem. 2005, 277:1-6.
26. Grober J. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the Farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 1999, 274:29749-29754.
27. Hwang S.T., Urizar N.L., Moore D.D., Henning S.J. Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 2002, 122:1483-1492.
28. Praslickova D., Torchia E.C., Sugiyama M.G., Magrane E.J., Zwicker B.L., Kolodzieyski L., et al. The ileal lipid binding protein is required for efficient absorption and transport of bile acids in the distal portion of the murine small intestine. PLoS One 2012, 7:e50810.
29. Agellon L.B., Toth M.J., Thomson A.B.R. Intracellular lipid binding proteins of the small intestine. Mol. Cell. Biochem. 2002, 239:79-82.
30. Richieri G.V, Ogata R.T., Zimmerman A.W., Veerkamp J.H., Kleinfeld A.M. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry 2000, 39:7197-7204.
31. Richieri G.V, Ogata R.T., Kleinfeld a M. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J. Biol. Chem. 1994, 269:23918-23930.
32. Storch J., Veerkamp J.H., Hsu K.-T. Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPs. Mol. Cell. Biochem. 2002, 239:25-33.
33. Hsu K.T., Storch J. Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J. Biol. Chem. 1996, 271:13317-13323.
34. Alpers D.H., Bass N.M., Engle M.J., DeSchryver-Kecskemeti K. Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine. Biochim. Biophys. Acta 2000, 1483:352-362.
35. Siddiqi S., Saleem U., Abumrad N.A., Davidson N.O., Storch J., Siddiqi S.A., et al. A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. J. Lipid Res. 2010, 51:1918-1928.
36. Issemann I., Prince R., Tugwood J., Green S. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?. Biochem. Soc. Trans. 1992, 20:824-827.
37. Nakamura M.T., Yudell B.E., Loor J.J. Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res. 2014, 53:124-144.
38. Mallordy A., Poirier H., Besnard P., Niot I., Carlier H. Evidence for transcriptional induction of the liver fatty-acid-binding-protein gene by bezafibrate in the small intestine. Eur. J. Biochem. 1995, 227:801-807.
39. Babeu J.-P., Boudreau F. Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks. World J. Gastroenterol. 2014, 20:22-30.
40. McIntosh A.L., Atshaves B.P., Hostetler H.a, Huang H., Davis J., Lyuksyutova O.I., et al. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes. Arch. Biochem. Biophys. 2009, 485:160-173.
41. Hostetler H.A., McIntosh A.L., Atshaves B.P., Storey S.M., Payne H.R., Kier A.B., et al. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes. J. Lipid Res. 2009, 50:1663-1675.
42. McIntosh A.L., Petrescu A.D., Hostetler H.A., Kier A.B., Schroeder F. Liver-type fatty acid binding protein interacts with hepatocyte nuclear factor 4α. FEBS Lett. 2013, 587:3787-3791.
43. Erol E., Kumar L.S., Cline G.W., Shulman G.I., Kelly D.P., Binas B. Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-alpha in fasting mice. FASEB J. 2004, 18:347-349.
44. Lagakos W.S., Gajda A.M., Agellon L., Binas B., Choi V., Mandap B., et al. Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G803-G814.
45. Gajda A.M., Zhou Y.X., Agellon L.B., Fried S.K., Kodukula S., Fortson W.M., et al. Direct comparison of mice null for liver- or intestinal fatty acid binding proteins reveals highly divergent phenotypic responses to high-fat feeding. J. Biol. Chem. 2013, 288:30330-30344.
46. Besnard P., Mallordy a, Carlier H. Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate. FEBS Lett. 1993, 327:219-223.
47. Poirier H., Niot I., Degrace P., Monnot M.C., Bernard A., Besnard P., et al. Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am. J. Physiol. - Gastrointest. Liver Physiol. 1997, 273:G289-G295.
48. Malewiak M., Bass N., Griglio S., Ockner R.K. Influence of genetic obesity and of fat-feeding on hepatic FABP concentration and activity. Int. J. Obes. 1988, 12:543-546.
49. Petit V., Arnould L., Martin P., Monnot M.-C., Pineau T., Besnard P., et al. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J. Lipid Res. 2007, 48:278-287.
50. Ockner R.K., Burnett D.A., Lysenko N., Manning J.A. Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver. J. Clin. Invest. 1979, 64:172-181.
51. Robitaille J., Brouillette C., Lemieux S., Pérusse L., Gaudet D., Vohl M.C. Plasma concentrations of apolipoprotein B are modulated by a gene--diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol. Genet. Metab. 2004, 82:296-303.
52. Brouillette C., Bossé Y., Pérusse L., Gaudet D., Vohl M.-C. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J. Hum. Genet. 2004, 49:424-432.
53. Fisher E., Weikert C., Klapper M., Lindner I., Möhlig M., Spranger J., et al. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol. Genet. Metab. 2007, 91:278-284.
54. Gao N., Qu X., Yan J., Huang Q., Yuan H.-Y., Ouyang D.-S. L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP. Mol. Cell. Biochem. 2010, 345:207-214.
55. Martin G.G., McIntosh A.L., Huang H., Gupta S., Atshaves B.P., Landrock K.K., et al. The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates. Biochemistry 2013, 52:9347-9357.
56. Sacchettini J.C., Hauft S.M., Van Camp S.L., Cistola D.P., Gordon J.I. Developmental and structural studies of an intracellular lipid binding protein expressed in the ileal epithelium. J. Biol. Chem. 1990, 265:19199-19207.
57. Neeli I., Siddiqi S.a, Siddiqi S., Mahan J., Lagakos W.S., Binas B., et al. Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum. J. Biol. Chem. 2007, 282:17974-17984.
58. Lowe J.B., Sacchettini J.C., Laposata M., McQuillan J.J., Gordon J.I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J. Biol. Chem. 1987, 262:5931-5937.
59. Franchini G.R., Storch J., Corsico B. The integrity of the alpha-helical domain of intestinal fatty acid binding protein is essential for the collision-mediated transfer of fatty acids to phospholipid membranes. Biochim. Biophys. Acta 1781, 2008:192-199.
60. Halldén G., Aponte G.W. Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids. J. Biol. Chem. 1997, 272:12591-12600.
61. Newberry E.P., Xie Y., Kennedy S., Han X., Buhman K.K., Luo J., et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J. Biol. Chem. 2003, 278:51664-51672.
62. Vassileva G., Huwyler L., Poirier K., Agellon L.B., Toth M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 2000, 14:2040-2046.
63. Besnard P., Niot I., Poirier H., Clément L., Bernard A. New insights into the fatty acid-binding protein (FABP) family in the small intestine. Mol. Cell. Biochem. 2002, 239:139-147.
64. Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.a, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 1995, 95:1281-1287.
65. Pratley R.E., Baier L., Pan D.A., Salbe A.D., Storlien L., Ravussin E., et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J. Lipid Res. 2000, 41:2002-2008.
66. Georgopoulos A., Aras O., Tsai M.Y. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J. Clin. Endocrinol. Metab. 2000, 85:3155-3160.
67. Agren J.J., Valve R., Vidgren H., Laakso M., Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1606-1610.
68. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi a, et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997, 40:706-710.
69. Baier L.J., Bogardus C., Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 1996, 271:10892-10896.
70. Levy E., Ménard D., Delvin E., Stan S., Mitchell G., Lambert M., et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem. 2001, 276:39679-39684.
71. Porter C.J.H., Trevaskis N.L., Charman W.N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 2007, 6:231-248.
72. Mansbach C.M., Dowell R.F. Uptake and metabolism of circulating fatty acids by rat intestine. Am. J. Physiol. 1982, 263:G927-G933.
73. Storch J., Zhou Y.X., Lagakos W.S. Metabolism of apical versus basolateral sn-2-monoacylglycerol and fatty acids in rodent small intestine. J. Lipid Res. 2008, 49:1762-1769.
74. Gangl A., Ockner R.K. Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control. J. Clin. Invest. 1975, 55:803-813.
75. Prows D., Murphy E., Schroeder F. Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-cells. Lipids 1995, 30:907-910.
76. Atshaves B.P., Martin G.G., Hostetler H.A., McIntosh A.L., Kier A.B., Schroeder F. Liver fatty acid-binding protein and obesity. J. Nutr. Biochem. 2010, 21:1015-1032.
77. Veerkamp J.H., van Kuppevelt T.H.M.S.M., Maatman R.G.H.J., Prinsen C.F.M. Structural and functional aspects of cytosolic fatty acid-binding proteins, Prostaglandins. Leukot. Essent. Fat. Acids 1993, 49:887-906.
78. Kazantzis M., Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochim. Biophys. Acta 1821, 2012:852-857.
79. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 2001, 276:14890-14895.
80. Bass N. Fatty acid-protein expression in the liver: its regulation and relationship to the zonation of fatty acid metabolism. Mol. Cell. Biochem. 1990, 98:167-176.
81. Hubbell T., Behnke W.D., Woodford J.K., Schroeder F. Recombinant liver fatty acid binding protein interacts with fatty acyl-coenzyme A. Biochemistry 1994, 33:3327-3334.
82. Martin G.G., Danneberg H., Kumar L.S., Atshaves B.P., Erol E., Bader M., et al. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. J. Biol. Chem. 2003, 278:21429-21438.
83. Newberry E.P., Xie Y., Kennedy S.M., Luo J., Davidson N.O. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 2006, 44:1191-1205.
84. Atshaves B.P., McIntosh A.L., Storey S.M., Landrock K.K., Kier A.B., Schroeder F. High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein gene-ablated mice. Lipids 2010, 45:97-110.
85. Martin G.G., Atshaves B.P., McIntosh A.L., Mackie J.T., Kier A.B., Schroeder F. Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity. J. Nutr. 2008, 138:1859-1865.
86. Martin G.G., Atshaves B.P., McIntosh A.L., Payne H.R., Mackie J.T., Kier A.B., et al. Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice. Mol. Cell. Biochem. 2009, 324:101-115.
87. McIntosh A.L., Atshaves B.P., Landrock D., Landrock K.K., Martin G.G., Storey S.M., et al. Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice. Lipids 2013, 48:435-448.
88. Newberry E.P., Kennedy S.M., Xie Y., Luo J., Davidson N.O. Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice. Mol. Cell. Biochem. 2009, 326:79-86.
89. Newberry E.P., Kennedy S.M., Xie Y., Sternard B.T., Luo J., Davidson N.O. Diet-induced obesity and hepatic steatosis in L-Fabp/mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G307-G314.
90. Newberry E.P., Davidson N.O., Acid Liver Fatty Binding Protein (L-FABP) as a Target for the Prevention of High Fat Diet Induced Obesity and Hepatic Steatosis. Immunol. Endocr. Metab. Agents - Med. Chem. (Formerly Curr. Med. Chem. - Immunol. Endocr. Metab. Agents) 2009, 9:30-37.
91. Newberry E.P., Kennedy S.M., Xie Y., Luo J., Crooke R.M., Graham M.J., et al. Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. J. Lipid Res. 2012, 53:744-754.
92. Williams M.A., Tamai K.T., Hincenbergs I., McIntosh D.J. Hydrogenated coconut oil and tissue fatty acids in EFA-depleted and EFA-supplemented rats. J. Nutr. 1972, 102:847-855.
93. Chen A., Tang Y., Davis V., Hsu F.-F., Kennedy S.M., Song H., et al. Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease. Hepatology 2013, 57:2202-2212.
94. C.R. Kahn, O. Bezy, S. Usar, N.W. Griffin, J.I. Gordon, Diabetes and obesity-nature vs nurture, in: Keystone Symp. Diabetes-New Insights into Mech. Dis. Its Treat., Keystone Symposia, Keystone, CO, n.d. 42.
95. Agellon L.B., Drozdowski L., Li L., Iordache C., Luong L., Clandinin M.T., et al. Loss of intestinal fatty acid binding protein increases the susceptibility of male mice to high fat diet-induced fatty liver. Biochim. Biophys. Acta 1771, 2007:1283-1288.
96. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
97. Chon S.-H., Douglass J.D., Zhou Y.X., Malik N., Dixon J.L., Brinker A., et al. Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity. PLoS One 2012, 7:e43962.
98. Storch J. Diversity of fatty acid-binding protein structure and function: studies with fluorescent ligands. Mol. Cell. Biochem. 1993, 123:45-53.
99. Niot I., Poirier H., Tran T.T.T., Besnard P. Intestinal absorption of long-chain fatty acids: Evidence and uncertainties. Prog. Lipid Res. 2009, 48:101-115.